| 000 | 01523 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250511225303.0 | ||
| 264 | 0 | _c19900417 | |
| 008 | 199004s 0 0 eng d | ||
| 022 | _a0028-3878 | ||
| 024 | 7 |
_a10.1212/wnl.40.3_part_1.479 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKastrukoff, L F | |
| 245 | 0 | 0 |
_aSystemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluation. _h[electronic resource] |
| 260 |
_bNeurology _cMar 1990 |
||
| 300 |
_a479-86 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBrain _xpathology |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aEvaluation Studies as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon Type I _xadverse effects |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xpathology |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aStatistics as Topic |
| 700 | 1 | _aOger, J J | |
| 700 | 1 | _aHashimoto, S A | |
| 700 | 1 | _aSacks, S L | |
| 700 | 1 | _aLi, D K | |
| 700 | 1 | _aPalmer, M R | |
| 700 | 1 | _aKoopmans, R A | |
| 700 | 1 | _aPetkau, A J | |
| 700 | 1 | _aBerkowitz, J | |
| 700 | 1 | _aPaty, D W | |
| 773 | 0 |
_tNeurology _gvol. 40 _gno. 3 Pt 1 _gp. 479-86 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.40.3_part_1.479 _zAvailable from publisher's website |
| 999 |
_c2185891 _d2185891 |
||